Juanita M. Crook, MD, FRCPC, presented “Treatment of Oligometastatic Disease” during the 26th Annual Southwest Prostate Cancer Symposium conference on April 15, 2023, in Scottsdale, Arizona.
How to cite: Crook, Juanita M. “Treatment of Oligometastatic Disease.” April 15, 2023. Accessed Oct 2026. https://grandroundsinurology.com/treatment-of-oligometastatic-disease/
Treatment of Oligometastatic Disease – Summary
Juanita M. Crook, MD, FRCPC defines the clinical criteria for oligometastatic prostate cancer, highlighting the significance of accurate staging and advanced imaging techniques in identifying patients who may benefit from targeted treatments. She emphasizes new evidence suggesting that aggressive local and systemic therapies can achieve prolonged disease control and possibly cure in select patients.
Dr. Crook presents various treatment modalities, including stereotactic body radiotherapy (SBRT), surgery, and systemic therapies such as androgen deprivation therapy (ADT) and novel hormonal agents. She presents data from recent clinical trials demonstrating the efficacy of SBRT in controlling metastatic lesions. Additionally, she explores the role of metastasis-directed therapy (MDT) in delaying the initiation of systemic treatments and reducing treatment-related side effects.
About the 26th Annual Southwest Prostate Cancer Symposium:
This conference educated attendees about advances in the management of localized and advanced prostate cancer, with a focus on imaging, technology, and training in the related devices. It included a scientific session, as well as live demonstrations of surgical techniques. You can learn more about the conference here.
ABOUT THE AUTHOR
Juanita M. Crook, MD, FRCPC, completed her medical training at the University of Toronto and her residency in Radiation Oncology at Princess Margaret Hospital. She is currently a Professor of Radiation Oncology at the University of British Columbia in Kelowna. She is a radiation oncologist at the BC Cancer Agency Sindi Ahluwalia Hawkins Centre for the Southern Interior, also in Kelowna, where she has developed image-guided HDR gynecologic brachytherapy, US-planned HDR prostate brachytherapy, and permanent seed brachytherapy for breast cancer. Previously a Professor of Radiation Oncology at the University of Toronto/University Health Network and an Associate Professor at the University of Ottawa, she has a particular interest in intermittent androgen suppression, post-radiation prostate biopsies, and penile brachytherapy. She has written more than 20 book chapters and over 200 journal articles and is a frequent speaker at international meetings where she presents in English, French, and Spanish. She was Scientific Chair of the 2007 American Brachytherapy Society meeting and frequently teaches at the ABS Prostate Brachytherapy School. She is the former President of the Board of the American Brachytherapy Society and the recipient of the Thom Shanahan Distinguished Brachytherapy Educator Award.
